0 results available. Select is focused ,type to refine list, press Down to open the menu,
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform ...
The following section summarizes insights on Insulet Corporation's Capital Expenditures Forecast (FINBOX):
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Capital Expenditures Forecast (FINBOX) in the forecast category include:
Projected capital expenditures.
The chart above depicts the distribution of capital expenditures forecast (finbox) for companies operating in the Healthcare sector in the Developed economic region. Over 2,560 companies were considered in this analysis, and 2,517 had meaningful values. The average capital expenditures forecast (finbox) of companies in the sector is 22.576 M with a standard deviation of 79.365 M.
Insulet Corporation's Capital Expenditures Forecast (FINBOX) of 124 M ranks in the 95.1% percentile for the sector. The following table provides additional summary stats:
Economic Risk Region | Developed |
Total Constituents | 2,568 |
Included Constituents | 2,517 |
Min | 0 K |
Max | 712.5 M |
Median | 843.093 K |
Mean | 22.576 M |
Standard Deviation | 79.365 M |
You can find companies with similar capital expenditures forecast (finbox) using this stock screener.